CAS: 96068-42-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol REF: 3D-WDA06842CAS: 96068-42-7 | Min. 95% | 180.00 €~780.00 € | Wed 26 Feb 25 |
 | SARS-CoV-2-IN-32 REF: TM-T63181CAS: 96068-42-7 | - - - | 2,023.00 €~3,328.00 € | Wed 12 Mar 25 |
4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol
CAS:96068-42-7
Please enquire for more information about 4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol including the price, delivery time and more detailed …
Formula:
C27H23N5O4
Purity:
Min. 95%
Molecular weight:
481.5 g/mol
Ref: 3D-WDA06842
| 25mg | 338.00 € | ||
| 50mg | 357.00 € | ||
| 100mg | 522.00 € | ||
| 250mg | 780.00 € |
Estimated delivery in United States, on Wednesday 26 Feb 2025
SARS-CoV-2-IN-32
CAS:96068-42-7
SARS-CoV-2-IN-32 inhibits COVID-19 (Mpro; PDB: 6LU7) and has anti-cancer effects; useful for related research.
Formula:
C27H23N5O4
Color and Shape:
Liquid
Molecular weight:
481.5
Ref: TM-T63181
| 25mg | 2,023.00 € | ||
| 50mg | 2,633.00 € | ||
| 100mg | 3,328.00 € |
Estimated delivery in United States, on Wednesday 12 Mar 2025
